AMENDMENT NO. 1 TO MERGER AGREEMENTMerger Agreement • October 9th, 2018 • Avista Healthcare Public Acquisition Corp. • Pharmaceutical preparations
Contract Type FiledOctober 9th, 2018 Company IndustryThis AMENDMENT NO. 1 TO MERGER AGREEMENT, dated as of October 5, 2018 (this “Amendment”), is made by and among Organogenesis Inc., a Delaware corporation (the “Company”), Avista Healthcare Public Acquisition Corp., a Cayman Islands exempted company (“Parent”) and Avista Healthcare Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (“Merger Sub”). Capitalized terms used herein but not specifically defined herein shall have the meanings ascribed to such terms in the Merger Agreement (as defined below).